Feb 22, 2019
Heron Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2018 and Recent Corporate Progress
Feb 13, 2019
MMJ Files FDA Fast Track Approval Application For Cannabis Multiple Sclerosis Drug
Feb 06, 2019
Upgrade! - THC BioMed Lists on the OTCQX Best Market
Feb 05, 2019
Heron Therapeutics Announces Retirement of Robert Rosen as President
Jan 29, 2019
Lights Out for Insomnia: New Kanabo Research Study Offers Encouraging Results
Jan 18, 2019
Khiron Life Sciences Launches Latin American Medical Education Program With Events in Colombia and Mexico
Jan 14, 2019
Third-Annual World Medical Cannabis Conference & Expo Heads East to Philadelphia
Jan 07, 2019
Heron Therapeutics Highlights Progress in Pain Management and CINV Franchises
Jan 02, 2019
Scientus Pharma Obtains Health Canada Approval for Sale of Dried Cannabis
Jan 02, 2019
Intec Pharma Advances Medical Cannabinoid Development Program With Dosing of First Patient in a Phase 1 Pharmacokinetic Study of Accordion Pill-THC
Dec 03, 2018
Vanda Announces Positive Phase II Study Results for Tradipitant in Patients with Gastroparesis
Nov 20, 2018
Innovative Test Developed by Navigator Genomics for Medical Cannabis & Prescription Drugs
Nov 12, 2018
Northern Green Sciences Takes on the Opioid Crisis
Nov 07, 2018
Heron Therapeutics Announces Financial Results for the Three and Nine Months Ended September 30, 2018 and Recent Corporate Progress
Nov 01, 2018
North American Cannabis Holdings Inc Executes AmeriCanna Cafe Spinoff and Announces Planned Dividend
Oct 30, 2018
London Startup, thedrug.store, Aims to Clean up Europe's CBD Industry
Oct 16, 2018
Duchesnay USA Continues the Morning Sickness Conversation with Actress, Mom and Singer Jana Kramer and Beverly Hills Ob/Gyn Dr. Jay Goldberg
Oct 03, 2018
Veterans and Families to Participate in Ribbon Cutting Launch of Compassionate Certification Centers(TM) Medical Cannabis Office in Erie
Oct 02, 2018
GB Sciences' Drug Development Program Benefits from Establishment of Clear Pathway for Cannabis-Based Drug Approvals and Commercialization
Oct 02, 2018
VerdeMed, a Latin America Cannabis Company, announces US$5.0M offering to finance the acquisition of a Colombian Licenced Producer and a Brazilian Pharmaceutical Laboratory